|
|
|
|
| LEADER |
00000cam a2200000 7i4500 |
| 001 |
0000091763 |
| 005 |
20170828.0 |
| 008 |
170530s2016 nyu eng |
| 020 |
|
|
|a 9781634836005
|
| 050 |
0 |
0 |
|a RM332
|b .S53 2016
|
| 060 |
1 |
0 |
|a QV77.5
|b .S531 2016
|
| 090 |
0 |
0 |
|a RM332
|b .S53 2016
|
| 100 |
1 |
|
|a Sharma, Sushil K. ,
|e author
|
| 245 |
1 |
0 |
|a Monoamine oxidase inhibitors :
|b clinical pharmacology, benefits, and potential health risks
|c Sushil K. Sharma
|
| 260 |
|
|
|a New York :
|b Nova Science Publishers ,
|c c2016
|
| 300 |
|
|
|a lii, 408 p. :
|b ill. ;
|c 26 cm.
|
| 504 |
|
|
|a Includes bibliographical references and index
|
| 505 |
0 |
|
|a 1. Therapeutic potential of MAOIs (historical perspective and earlier studies) -- 2. Synthetic and herbal MAOIs -- 3. Molecular pharmacology of monoamine oxidase inhibitors -- 4. Specific monoamine-oxidase-a inhibitors (moclobemide, safinamide, and lazabemide) -- 5. Specific MAO-B inhibitors (therapeutic role of selegiline and rasagiline) -- 6. Therapeutic potential of MAOIs (recent update-1) -- 7. Therapeutic potential of MAOIs (recent update 2) -- 8. Therapeutic potential of MAOIs (recent update 3) -- 9. Therapeutic potential of MAOIs (recent update 4) -- 10. Therapeutic potential of MAOIs (recent update 5) -- 11. Therapeutic potential of MAOIs (recent update 6) -- 12. Dietary and drug restrictions with MAOIs -- 13. Adverse reactions with MAOIs (recent update)
|
| 650 |
|
0 |
|a Monoamine oxidase
|v Inhibitors
|x Therapeutic use.
|
| 999 |
|
|
|a 1000169204
|b Book
|c OPEN SHELF (30 DAYS)
|e Tembila Campus
|